Case Report Warns of Pneumothorax Risk in Duchenne Muscular Dystrophy
March 6th 2024The authors of this report stress the importance of awareness of COVID-19–related complications in young patients who have Duchenne muscular dystrophy, paying particular attention to a potential higher risk of respiratory infections in these patients.
Read More
AAD 2024 to Feature Topics Including JAK Inhibitors, Biologics
March 6th 2024The American Academy of Dermatology (AAD) will host its annual conference in San Diego from March 8 to March 11, 2024, which will include sessions about Janus kinase (JAK) inhibitors, biologics, and other treatments for skin disorders.
Read More
Stable Treatment Remained in Early Breast Cancer Diagnosis During Pandemic
March 6th 2024A study of patients diagnosed with early breast cancer during the COVID-19 pandemic found that the public health crisis did not produce significant changes in or delays treatment, despite many women presenting with palpable tumors.
Read More
Promise of AI in MS Research and Treatment Showcased at ACTRIMS 2024
March 3rd 2024The poster session at the Americas Committee for Research and Treatment in Multiple Sclerosis (ACTRIMS) Forum 2024 dedicated a section to emerging developments in the use of artificial intelligence (AI) in research and treatment approaches in multiple sclerosis (MS).
Read More
Highlighting Progress, Addressing Unmet Needs in MS Rehabilitation Trials
March 3rd 2024Speakers on the final day of the Americas Committee for Research and Treatment in Multiple Sclerosis (ACTRIMS) Forum 2024 discussed advancements in rehabilitation trials in multiple sclerosis (MS) and unmet research needs.
Read More
Imaging and 3D Modeling a Key Focus at ACTRIMS 2024
March 2nd 2024On day 2 of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024, speakers gave great attention to novel developments in the field of imaging and 3D modeling in multiple sclerosis (MS).
Read More